ArticleMolecular cancer therapeutics2011

Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.

Nate N Waldron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.